Checkpoint inhibitors for melanoma ... and other research

被引:0
|
作者
Nolan, Tom
机构
来源
关键词
D O I
10.1136/bmj.q2081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Treatment patterns of checkpoint inhibitors in metastatic melanoma
    Machado, Marina A. A.
    Moura, Cristiano S.
    Curtis, Jeffrey R.
    Hudson, Marie
    Bernatsky, Sasha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 395 - 396
  • [22] Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
    Fujimura, Taku
    Muto, Yusuke
    Asano, Yoshihide
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [23] Immune checkpoint inhibitors.. . and other stories
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 2025, 388
  • [24] Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)
    Bhave, P.
    Ahmed, T.
    Shoushtari, A. N.
    Zaremba, A.
    Versluis, J. M.
    Mangana, J.
    Weichenthal, M.
    Si, L.
    Lesimple, T.
    Robert, C.
    Trojaniello, C.
    Wicky, A.
    Heywood, R.
    Tran, L.
    Batty, K.
    Stansfeld, A.
    Lebbe, C.
    Schwarze, J. K.
    Mooradian, M.
    Carlino, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S876 - S877
  • [25] Efficacy of immune checkpoint inhibitors in different types of melanoma
    Rossi, Ernesto
    Schinzari, Giovanni
    Maiorano, Brigida Anna
    Indellicati, Giulia
    Di Stefani, Alessandro
    Pagliara, Monica Maria
    Fragomeni, Simona Maria
    De Luca, Erika Valentina
    Sammarco, Maria Grazia
    Garganese, Giorgia
    Galli, Jacopo
    Blasi, Maria Antonietta
    Paludetti, Gaetano
    Scambia, Giovanni
    Peris, Ketty
    Tortora, Giampaolo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 4 - 13
  • [26] Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)
    Bhave, Prachi
    Ahmed, Tasnia
    Shoushtari, Alexander
    Zaremba, Anne
    Versluis, Judith
    Mangana, Joanna
    Weichenthal, Michael
    Si, Lu
    Lesimple, Thierry
    Robert, Caroline
    Trojaniello, Claudia
    Wicky, Alexandre
    Heywood, Richard
    Tran, Lena
    Batty, Kathleen
    Stansfeld, Anna
    Lebbe, Celeste
    Schwarze, Julia K.
    Mooradian, Meghan
    Carlino, Matteo S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 64 - 65
  • [27] Sarcoidosis related to checkpoint and BRAF/MEK inhibitors in melanoma
    Rubio-Rivas, Manuel
    Moreira, Catarina
    Marcoval, J.
    AUTOIMMUNITY REVIEWS, 2020, 19 (08)
  • [28] Novel predictive biomarkers in melanoma treatment with checkpoint inhibitors
    Gebhardt, C.
    Sevko, A.
    Jiang, H.
    Lichtenberger, R.
    Schafer, K.
    Reith, M.
    Tarnanidis, K.
    Umansky, L.
    Beckhove, P.
    Sucker, A.
    Schadendorf, D.
    Umansky, V
    Utikal, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 13 - 13
  • [29] Mechanisms of primary resistance to immune checkpoint inhibitors in Melanoma
    Moogk, Duane
    Wang, Lin
    Li, Kaitao
    Yuan, Zhou
    Zhong, Shi
    Yu, Zhiya
    Liadi, Ivan
    Rittase, William
    Fang, Victoria
    Dougherty, Janna
    Perez-Garcia, Arianne
    Varadarajan, Navin
    Restifo, Nicholas P.
    Frey, Alan
    Osman, Iman
    Weber, Jeff
    Zhu, Cheng
    Krogsgaard, Michelle
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [30] Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapy
    O'reilly, Aine
    Larkin, James
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (07) : 647 - 655